Assessment  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
cardiac  ||| S:14 E:22 ||| JJ
contractile  ||| S:22 E:34 ||| NNS
reserve  ||| S:34 E:42 ||| VBP
Left  ||| S:42 E:47 ||| VBN
ventricular  ||| S:47 E:59 ||| NNS
( ||| S:59 E:60 ||| -LRB-
LV ||| S:60 E:62 ||| NNP
)  ||| S:62 E:64 ||| -RRB-
function  ||| S:64 E:73 ||| NN
is  ||| S:73 E:76 ||| VBZ
usually  ||| S:76 E:84 ||| RB
measured  ||| S:84 E:93 ||| VBN
by  ||| S:93 E:96 ||| IN
imaging  ||| S:96 E:104 ||| JJ
modalities  ||| S:104 E:115 ||| JJ
such  ||| S:115 E:120 ||| JJ
as  ||| S:120 E:123 ||| IN
echocardiography  ||| S:123 E:140 ||| NN
under  ||| S:140 E:146 ||| IN
static  ||| S:146 E:153 ||| JJ
conditions  ||| S:153 E:164 ||| NNS
in  ||| S:164 E:167 ||| IN
patients  ||| S:167 E:176 ||| NNS
with  ||| S:176 E:181 ||| IN
dilated  ||| S:181 E:189 ||| JJ
cardiomyopathy  ||| S:189 E:204 ||| NNS
( ||| S:204 E:205 ||| -LRB-
DCM ||| S:205 E:208 ||| NNP
) ||| S:208 E:209 ||| -RRB-
.  ||| S:209 E:211 ||| .
However ||| S:211 E:218 ||| RB
,  ||| S:218 E:220 ||| ,
some  ||| S:220 E:225 ||| DT
studies  ||| S:225 E:233 ||| NNS
have  ||| S:233 E:238 ||| VBP
reported  ||| S:238 E:247 ||| VBN
that  ||| S:247 E:252 ||| IN
LV  ||| S:252 E:255 ||| NNP
contractile  ||| S:255 E:267 ||| JJ
function  ||| S:267 E:276 ||| NN
at  ||| S:276 E:279 ||| IN
rest  ||| S:279 E:284 ||| NN
is  ||| S:284 E:287 ||| VBZ
not  ||| S:287 E:291 ||| RB
reliable  ||| S:291 E:300 ||| JJ
for  ||| S:300 E:304 ||| IN
assessment  ||| S:304 E:315 ||| NN
of  ||| S:315 E:318 ||| IN
the  ||| S:318 E:322 ||| DT
reversibility  ||| S:322 E:336 ||| NN
of  ||| S:336 E:339 ||| IN
LV  ||| S:339 E:342 ||| NNP
contraction ||| S:342 E:353 ||| NN
.  ||| S:353 E:355 ||| .
Therefore ||| S:355 E:364 ||| RB
,  ||| S:364 E:366 ||| ,
it  ||| S:366 E:369 ||| PRP
is  ||| S:369 E:372 ||| VBZ
important  ||| S:372 E:382 ||| JJ
to  ||| S:382 E:385 ||| TO
evaluate  ||| S:385 E:394 ||| VB
LV  ||| S:394 E:397 ||| JJ
functional  ||| S:397 E:408 ||| JJ
response  ||| S:408 E:417 ||| NN
under  ||| S:417 E:423 ||| IN
dynamic  ||| S:423 E:431 ||| JJ
conditions  ||| S:431 E:442 ||| NNS
by  ||| S:442 E:445 ||| IN
use  ||| S:445 E:449 ||| NN
of  ||| S:449 E:452 ||| IN
pharmacological  ||| S:452 E:468 ||| NN
as  ||| S:468 E:471 ||| IN
well  ||| S:471 E:476 ||| RB
as  ||| S:476 E:479 ||| IN
exercise  ||| S:479 E:488 ||| NN
stress  ||| S:488 E:495 ||| NN
( ||| S:495 E:496 ||| -LRB-
contractile  ||| S:496 E:508 ||| JJ
reserve ||| S:508 E:515 ||| NN
) ||| S:515 E:516 ||| -RRB-
.  ||| S:516 E:518 ||| .
In  ||| S:518 E:521 ||| IN
our  ||| S:521 E:525 ||| PRP$
studies ||| S:525 E:532 ||| NNS
,  ||| S:532 E:534 ||| ,
LVdP ||| S:534 E:538 ||| JJ
/ ||| S:538 E:539 ||| CD
dtmax  ||| S:539 E:545 ||| NNS
was  ||| S:545 E:549 ||| VBD
measured  ||| S:549 E:558 ||| VBN
at  ||| S:558 E:561 ||| IN
rest  ||| S:561 E:566 ||| NN
and  ||| S:566 E:570 ||| CC
under  ||| S:570 E:576 ||| IN
dobutamine  ||| S:576 E:587 ||| JJ
stress  ||| S:587 E:594 ||| NN
using  ||| S:594 E:600 ||| VBG
a  ||| S:600 E:602 ||| DT
pigtail  ||| S:602 E:610 ||| JJ
catheter  ||| S:610 E:619 ||| NN
with  ||| S:619 E:624 ||| IN
a  ||| S:624 E:626 ||| DT
high-fidelity  ||| S:626 E:640 ||| NN
micromanometer  ||| S:640 E:655 ||| VBZ
placed  ||| S:655 E:662 ||| VBN
into  ||| S:662 E:667 ||| IN
the  ||| S:667 E:671 ||| DT
left  ||| S:671 E:676 ||| JJ
ventricle  ||| S:676 E:686 ||| NN
in  ||| S:686 E:689 ||| IN
DCM  ||| S:689 E:693 ||| NNP
patients.  ||| S:693 E:703 ||| NNP
deltaVdP ||| S:703 E:711 ||| NNP
/ ||| S:711 E:712 ||| NNP
dtmax  ||| S:712 E:718 ||| NN
as  ||| S:718 E:721 ||| IN
an  ||| S:721 E:724 ||| DT
index  ||| S:724 E:730 ||| NN
of  ||| S:730 E:733 ||| IN
myocardial  ||| S:733 E:744 ||| JJ
contractile  ||| S:744 E:756 ||| JJ
reserve  ||| S:756 E:764 ||| NN
was  ||| S:764 E:768 ||| VBD
defined  ||| S:768 E:776 ||| VBN
as  ||| S:776 E:779 ||| IN
the  ||| S:779 E:783 ||| DT
percentage  ||| S:783 E:794 ||| NN
increase  ||| S:794 E:803 ||| NN
in  ||| S:803 E:806 ||| IN
LVdP ||| S:806 E:810 ||| NNP
/ ||| S:810 E:811 ||| NNP
dtmax  ||| S:811 E:817 ||| VBD
induced  ||| S:817 E:825 ||| VBN
by  ||| S:825 E:828 ||| IN
dobutamine  ||| S:828 E:839 ||| JJ
infusion ||| S:839 E:847 ||| NN
.  ||| S:847 E:849 ||| .
Firstly ||| S:849 E:856 ||| NNP
,  ||| S:856 E:858 ||| ,
deltaLVdP ||| S:858 E:867 ||| JJ
/ ||| S:867 E:868 ||| CD
dtmax  ||| S:868 E:874 ||| NNS
was  ||| S:874 E:878 ||| VBD
correlated  ||| S:878 E:889 ||| VBN
with  ||| S:889 E:894 ||| IN
peak  ||| S:894 E:899 ||| JJ
oxygen  ||| S:899 E:906 ||| NN
consumption  ||| S:906 E:918 ||| NN
by  ||| S:918 E:921 ||| IN
cardiopulmonary  ||| S:921 E:937 ||| JJ
exercise  ||| S:937 E:946 ||| NN
testing ||| S:946 E:953 ||| NN
.  ||| S:953 E:955 ||| .
In  ||| S:955 E:958 ||| IN
addition ||| S:958 E:966 ||| NN
,  ||| S:966 E:968 ||| ,
impaired  ||| S:968 E:977 ||| VBN
deltaLVdP ||| S:977 E:986 ||| JJ
/ ||| S:986 E:987 ||| CD
dtmax  ||| S:987 E:993 ||| NNS
was  ||| S:993 E:997 ||| VBD
associated  ||| S:997 E:1008 ||| VBN
with  ||| S:1008 E:1013 ||| IN
unfavorable  ||| S:1013 E:1025 ||| JJ
prognosis ||| S:1025 E:1034 ||| NN
.  ||| S:1034 E:1036 ||| .
Secondly ||| S:1036 E:1044 ||| RB
,  ||| S:1044 E:1046 ||| ,
reduced  ||| S:1046 E:1054 ||| VBD
deltaLVdP ||| S:1054 E:1063 ||| JJ
/ ||| S:1063 E:1064 ||| CD
dtmax  ||| S:1064 E:1070 ||| NNS
was  ||| S:1070 E:1074 ||| VBD
associated  ||| S:1074 E:1085 ||| VBN
with  ||| S:1085 E:1090 ||| IN
an  ||| S:1090 E:1093 ||| DT
increased  ||| S:1093 E:1103 ||| JJ
washout  ||| S:1103 E:1111 ||| JJ
rate  ||| S:1111 E:1116 ||| NN
evaluated  ||| S:1116 E:1126 ||| VBN
by  ||| S:1126 E:1129 ||| IN
myocardial  ||| S:1129 E:1140 ||| JJ
123I-MIBG  ||| S:1140 E:1150 ||| NN
and  ||| S:1150 E:1154 ||| CC
99mTc-MIBI  ||| S:1154 E:1165 ||| CD
scintigraphy ||| S:1165 E:1177 ||| NNS
.  ||| S:1177 E:1179 ||| .
Finally ||| S:1179 E:1186 ||| RB
,  ||| S:1186 E:1188 ||| ,
this  ||| S:1188 E:1193 ||| DT
residual  ||| S:1193 E:1202 ||| JJ
contractile  ||| S:1202 E:1214 ||| JJ
reserve  ||| S:1214 E:1222 ||| NN
was  ||| S:1222 E:1226 ||| VBD
related  ||| S:1226 E:1234 ||| VBN
to  ||| S:1234 E:1237 ||| TO
molecular  ||| S:1237 E:1247 ||| VB
remodeling  ||| S:1247 E:1258 ||| VBG
caused  ||| S:1258 E:1265 ||| VBN
by  ||| S:1265 E:1268 ||| IN
overactivation  ||| S:1268 E:1283 ||| NN
of  ||| S:1283 E:1286 ||| IN
the  ||| S:1286 E:1290 ||| DT
sympathetic  ||| S:1290 E:1302 ||| JJ
nerve  ||| S:1302 E:1308 ||| NN
system  ||| S:1308 E:1315 ||| NN
in  ||| S:1315 E:1318 ||| IN
DCM  ||| S:1318 E:1322 ||| NNP
patients ||| S:1322 E:1330 ||| NNS
.  ||| S:1330 E:1332 ||| .
This  ||| S:1332 E:1337 ||| DT
review  ||| S:1337 E:1344 ||| NN
focused  ||| S:1344 E:1352 ||| VBN
on  ||| S:1352 E:1355 ||| IN
the  ||| S:1355 E:1359 ||| DT
current  ||| S:1359 E:1367 ||| JJ
status  ||| S:1367 E:1374 ||| NN
of  ||| S:1374 E:1377 ||| IN
contractile  ||| S:1377 E:1389 ||| JJ
reserve  ||| S:1389 E:1397 ||| NN
with  ||| S:1397 E:1402 ||| IN
our  ||| S:1402 E:1406 ||| PRP$
findings ||| S:1406 E:1414 ||| NNS
,  ||| S:1414 E:1416 ||| ,
including  ||| S:1416 E:1426 ||| VBG
procedures  ||| S:1426 E:1437 ||| NNS
for  ||| S:1437 E:1441 ||| IN
evaluating  ||| S:1441 E:1452 ||| VBG
contractile  ||| S:1452 E:1464 ||| JJ
reserve ||| S:1464 E:1471 ||| NN
,  ||| S:1471 E:1473 ||| ,
clinical  ||| S:1473 E:1482 ||| JJ
implications ||| S:1482 E:1494 ||| NNS
,  ||| S:1494 E:1496 ||| ,
and  ||| S:1496 E:1500 ||| CC
molecular  ||| S:1500 E:1510 ||| JJ
biological  ||| S:1510 E:1521 ||| JJ
significance ||| S:1521 E:1533 ||| NN
.  ||| S:1533 E:1535 ||| .
